VolitionRX Ltd VNRX 深 滬
等待開盤 05-19 09:30:00 美东时间
2.27
+0.270
+13.50%
華盛通- 最 高2.32
- 今 開1.94
- 成交量 23.66万股
- 最 低 1.906
- 昨 收 2.00
- 總市值 1890.97万
- 52周最高 18.80
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 1.906
- 委 比 -14.29%
- 總股本 833.03万
- 歷史最高 185.60
- 量 比 1.19
- 振 幅 20.70%
- 歷史最低 1.906
- 每 手 1
- 風險率 4.19%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Full Transcript: VolitionRX Q1 2026 Earnings Call
VolitionRX (AMEX:VNRX) held its first-quarter earnings conference call on Frida...
05-15 21:46
VolitionRX Q1 EPS $(0.97) Misses $(0.75) Estimate, Sales $985.076K Beat $426.600K Estimate
VolitionRX (AMEX:VNRX) reported quarterly losses of $(0.97) per share which missed the analyst consensus estimate of $(0.75) by 29.33 percent. This is a 1516.67 percent decrease over losses of $(0.06) per share from the
05-15 04:26
Earnings Scheduled For May 14, 2026
Companies Reporting Before The Bell • Urban One (NASDAQ:UONEK) is expected to r...
05-14 19:11
VolitionRx Submits Clinical Manuscript For Peer Review Over Its Nu.Q Vet Feline Prototype Assay To Trace Lymphoma In Cats
VolitionRx Limited (NYSE:VNRX) ("Volition"), a multi-national epigenetics company, announces submission for peer review a clinical manuscript1 reporting the high accuracy of its Nu.Q® Vet Feline prototype assay in
05-06 20:20
VolitionRx Announces Submission of Manuscript for Nu.Q® Vet Cancer Test in Cats
The publication of this study in a peer reviewed journal is expected subsequently to unlock a $5 million contractual milestone payment HENDERSON, Nev., May 6, 2026 /PRNewswire/ -- VolitionRx...
05-06 20:17
D. Boral Capital Downgrades VolitionRX to Hold
D. Boral Capital analyst Jason Kolbert downgrades VolitionRX (AMEX:VNRX) from Buy to Hold.
04-20 20:41
VolitionRx Launches Online Store After 10 Years Of Research Into Cancer Testing Tools, Starts Selling Lab-Ready Nucleosome Products Online To Boost Research Use
VolitionRx Limited (NYSE:VNRX) ("Volition"), a multi-national epigenetics company, announces the launch of its rNuQ webshop offering a range of reliable, ready to use recombinant nucleosomes that we have developed over
04-20 19:35
Volition Launches rNuQ™ Webshop Broadening Product Range
HENDERSON, Nev., April 20, 2026 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, announces the launch of its rNuQ webshop offering...
04-20 19:30
美股大行评级 | 摩根大通上调霸王茶姬至"超配"，目标价上调至16美元；康尼格拉食品遭高盛、瑞银等7家机构下调目标价
今日重点评级关注：Leerink Partners：维持Camp4 Therapeutics"跑赢大市"评级，目标价从8美元升至9美元；韦德布什：维持Arcus Biosciences"跑赢大市"评级，目标价从37美元升至41美元
04-06 16:27
VolitionRx Earnings Call: Breakthroughs Amid Funding Strain
VolitionRX Ltd. (($VNRX)) has held its Q4 earnings call. Read on for the main h...
04-05 08:07
